Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

PTHrP is important for bone formation and may be targeted for osteoporosis treatment and longevity therapies.

A 13-year-old boy with a rare genetic condition survived a heart attack and improved with treatment.

Researchers created a new mouse model for studying scleroderma.

Women with alopecia may have a higher chance of getting thyroid cancer.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Overexpression of the glucocorticoid receptor in mice causes developmental defects similar to ectodermal dysplasia.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

A boy with toxic shock syndrome had severe heart rhythm problems but recovered with treatment.

Autoimmune hepatitis in children often affects girls and can be treated successfully with medication.

Microcolumn grafting can effectively regenerate full-thickness, functional skin without scarring.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

Follicular mucinosis in a 15-year-old is usually harmless but needs monitoring for possible lymphoma.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

FTase and GGTase-I are essential for skin keratinocyte health.

Trichothiodystrophy hair is structurally abnormal with protein and organization issues.

Basaloid follicular hamartoma is a rare, benign skin growth often misdiagnosed.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Lack of TrkC receptor delays hair follicle development.

Adults with alopecia areata often have empty follicular openings, while children show more honeycomb pigment patterns.

Alopecia areata may be caused by the immune system attacking hair follicles.

A new gene causes hairlessness and skin cysts in rats.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Two siblings were found to have a genetic condition causing progressive hair loss and woolly hair, which may often be misdiagnosed.